Frontiers | Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy | Immunology
CD8+ T Cells | Technology Networks
Frontiers | Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling | Immunology
The opposing roles of CD4+ T cells in anti‐tumour immunity - Ahrends - 2018 - Immunology - Wiley Online Library
Tumor-specific CD4 + , CD8 + T-cell and antibody responses induced by... | Download Scientific Diagram
The holy grail: pan-cancer-targeting T cells
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment - ScienceDirect
Cancers | Free Full-Text | The Potential of T Cell Factor 1 in Sustaining CD8+ T Lymphocyte-Directed Anti-Tumor Immunity
Resident memory T cells, critical components in tumor immunology | Journal for ImmunoTherapy of Cancer | Full Text
The Roles of CD8+ T Cell Subsets in Antitumor Immunity: Trends in Cell Biology
RETRACTED ARTICLE: A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function | Communications Biology
Intratumoral CD8+ T cells with stem cell–like properties: Implications for cancer immunotherapy
NR4A and TOX Transcription Factors Mediate CD8+ T Cell Exhaustion
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Naive CD8+ T Cells Expressing CD95 Increase Human Cardiovascular Disease Severity | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment | Immunology
JCI Insight - CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
Associations Between T-Cell Marker Densities in Normal and Tumor Tissue... | Download Table
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
Pan-cancer single-cell landscape of tumor-infiltrating T cells
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment | PNAS
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy | British Journal of Cancer
The good (T cells), the bad (T cells), and the ugly (tumor)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment | PNAS
Frontiers | Adaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens | Immunology
Frontiers | Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy | Immunology
